ZEMA Pharma Consulting ApS: Financial statements 2022
CVR: 42680427
Source: annual report 2022, Danish Business Authority
15/09/2021 – 30/09/2022
ZEMA Pharma Consulting ApS (CVR 42680427) has filed annual accounts for 2022. In 2022, the company reported a gross profit of DKK 1,146,083 and a net result of DKK 789,558. Equity in the 2022 report amounted to DKK 829,558. The solvency ratio was 69.9%. The company had 1 employee in the financial year.
- Gross Profit
- DKK 1,146,083
- Profit/Loss
- DKK 789,558
- Equity
- DKK 829,558
- Total Assets
- DKK 1,187,225
- Employees
- 1
Official annual report
Keep an eye on ZEMA Pharma Consulting ApS
Get notified instantly about new financial statements, ownership changes, management changes and status changes.
Set up monitoringAbout ZEMA Pharma Consulting ApS
ZEMA Pharma Consulting ApS is a Danish company of the type Anpartsselskab based in Dyssegård, founded in 2021. The company is registered under the industry Virksomhedsrådgivning og anden ledelsesrådgivning. The management consists of Mads Torkild Hansen. The company is owned by Mads Torkild Hansen. The company has 1 employee (2026). In 2025, the company reported a gross profit of DKK 102,227 and a net result of DKK -216,744 compared with DKK -281,625 the year before. Equity in the 2025 report amounted to DKK 354,543.
